7,688.62

+119.70

+1.58%

53,356.12

+1,569.40

+3.03%

25,736.51

+364.50

+1.44%

2,856.95

+44.50

+1.58%

4.8940

-0.0580

-1.17%

16.61

-4.22

-20.26%

4,072.40

-0.60

-0.01%

80,610.23

+3,273.48

+4.23%

Crude Oil Dec 26

88.16

+0.04

+0.05%

US Private Equity

10,855.23

+18.94

+0.17%

NasdaqGS - Delayed Quote USD

(VTYX)

-- -- --

Loading Chart for VTYX

Chart Range Bar

Interval:

In partnership with ChartIQ

How Eli Lilly's Plan To Buy Ventyx For $1.2 Billion Could Benefit Neumora, Neurocrine

How Eli Lilly's Plan To Buy Ventyx For $1.2 Billion Could Benefit Neumora, Neurocrine

Eli Lilly acquires inflammatory specialist Ventyx for $1.2bn

Eli Lilly acquires inflammatory specialist Ventyx for $1.2bn

Ventyx Biosciences Launches On Reported $1 Billion Eli Lilly Takeover

Ventyx Biosciences Launches On Reported $1 Billion Eli Lilly Takeover

Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns

Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns

Stock Market Today, Jan. 20: Corvus Pharmaceuticals Surges After Positive Phase 1 Eczema Drug Data

Stock Market Today, Jan. 20: Corvus Pharmaceuticals Surges After Positive Phase 1 Eczema Drug Data

Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million

Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million

Eli Lilly, BioAge chase NLRP3 inhibitors with ‘pipeline in a pill’ potential

Eli Lilly, BioAge chase NLRP3 inhibitors with ‘pipeline in a pill’ potential

Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress

Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress

Lilly Stock Down 5% in a Month: Should You Buy Now or Steer Clear?

Lilly Stock Down 5% in a Month: Should You Buy Now or Steer Clear?

Assessing Ventyx Biosciences (VTYX) Valuation After Sharp Share Price Momentum And A High P/B Multiple

Assessing Ventyx Biosciences (VTYX) Valuation After Sharp Share Price Momentum And A High P/B Multiple

Eli Lilly and Company (LLY) to Acquire Ventyx Biosciences

Eli Lilly and Company (LLY) to Acquire Ventyx Biosciences

Mobilize your Website

View Site in Mobile | Classic

Share by: